Title
Generation of a mouse model lacking the non-homologous end-joining factor Mri/Cyren
Date Issued
01 January 2019
Access level
open access
Resource Type
journal article
Author(s)
Huse C.
Røsand Ø.
Sarno A.
Xing M.
Gago-Fuentes R.
Zhang Q.
Alirezaylavasani A.
Werner J.
Ji P.
Liabakk N.B.
Wang W.
Bjørås M.
Oksenych V.
Norwegian University of Science and Technology
Publisher(s)
MDPI AG
Abstract
Classical non-homologous end joining (NHEJ) is a molecular pathway that detects, processes, and ligates DNA double-strand breaks (DSBs) throughout the cell cycle. Mutations in several NHEJ genes result in neurological abnormalities and immunodeficiency both in humans and mice. The NHEJ pathway is required for V(D)J recombination in developing B and T lymphocytes, and for class switch recombination in mature B cells. The Ku heterodimer formed by Ku70 and Ku80 recognizes DSBs and facilitates the recruitment of accessory factors (e.g., DNA-PKcs, Artemis, Paxx and Mri/Cyren) and downstream core factor subunits X-ray repair cross-complementing group 4 (XRCC4), XRCC4-like factor (XLF), and DNA ligase 4 (Lig4). Accessory factors might be dispensable for the process, depending on the genetic background and DNA lesion type. To determine the physiological role of Mri in DNA repair and development, we introduced a frame-shift mutation in the Mri gene in mice. We then analyzed the development of Mri-deficient mice as well as wild type and immunodeficient controls. Mice lacking Mri possessed reduced levels of class switch recombination in B lymphocytes and slow proliferation of neuronal progenitors when compared to wild type littermates. Human cell lines lacking Mri were as sensitive to DSBs as the wild type controls. Overall, we concluded that Mri/Cyren is largely dispensable for DNA repair and mouse development.
Volume
9
Issue
12
Language
English
OCDE Knowledge area
Genética, Herencia
Scopus EID
2-s2.0-85075789434
PubMed ID
Source
Biomolecules
Sponsor(s)
Funding text 1 Acknowledgments: We gratefully acknowledge support by the Molecular Imaging Core Facility (CMIC) and Comparative Medicine Core Facility (CoMed) at the Faculty of Medicine and Health Sciences, NTNU (Trondheim). Funding text 2 Funding: This work was supported by the Research Council of Norway Young Talent Investigator grant (#249774) to V.O. In addition, VO’s group was supported by the Liaison Committee for Education, Research, and Innovation in Central Norway (#13477); the Norwegian Cancer Society (#182355); FRIMEDBIO grants (#270491 and #291217), and The Outstanding Academic Fellow Program at NTNU (2017–2021). JW is supported by the Erasmus mobility program.
Sources of information: Directorio de Producción Científica Scopus